Abstract
Pharmacology is the study of drug action and applications in living organisms. A significant aspect of pharmacology is the use of natural, semi-synthetic, and synthetic products in the prophylaxis or treatment of disease. Observations from nature are increasingly being adopted and adapted to solve real world challenges. Potential solutions to challenges of restoring biological systems to normal function may lie in normally functioning biological systems. Biomimetics is learning from nature and using nature’s methods in science and engineering. This review is based on a literature search of Medline conducted within the first week of October 2016, limited to articles published between 2005 and 5th October 2016. Search terms were Biomimetics and Pharmacology. The most recent 100 publications were used to determine emerging themes and interphases of Biomimetics and Pharmacology. Using the 100 most recent publications from the search, the emerging themes were biomaterial scaffolds (26%), bio-molecules with enhanced or novel pharmacologic properties (24%), nano-particles (11%), cancer therapeutics (9%), biomimetics method applied to pharmacology (6%), novel and improved antimicrobials (6%), stem cell science (4%), regenerative medicine (3%), siRNA molecules (2%), and molecule biosensors (1%). This review describes these themes using a few examples from literature. Advances in biomimetic research are rapidly expanding the scope of pharmacology and creating new themes and trends. These emerging themes are giving rise to new sub-specialties in pharmacology. However, great science will remain a multidisciplinary collaboration in one big venture—to keep improving the quality of life on earth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
de Chaisemartin, L., Loriot, M.A.: Pharmacogenetics of anticancer drugs. Pathol. Biol. (Paris) 53, 116–124 (2005)
Goerig, M., Esch, J.: Friedrich Wilhelm Adam Sertürner—the discoverer of morphine Anasthesiol Intensivmed Notfallmed Schmerzther 26, 492–498 (1991)
Chang, J., Kwon, H.J.: Discovery of novel drug targets and their functions using phenotypic screening of natural products. J. Ind. Microbiol. Biotechnol. 43, 221–231 (2016)
Williams, L.A., O’Connar, A., Latore, L., Dennis, O., Ringer, S., Whittaker, J.A., Conrad, J., Vogler, B., Rosner, H., Kraus, W.: The in vitro anti-denaturation effects induced by natural products and non-steroidal compounds in heat treated (immunogenic) bovine serum albumin is proposed as a screening assay for the detection of anti-inflammatory compounds, without the use of animals, in the early stages of the drug discovery process. West Indian Med. J. 57, 327–331 (2008)
Luesch, H., Abreu, P.: A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening. Methods Mol. Biol. 572, 261–277 (2009)
Lahlou, M.: Screening of natural products for drug discovery. Expert Opin. Drug Discov. 2, 697–705 (2007)
Hwang, J., Jeong, Y., Park, J.M., Lee, K.H., Hong, J.W., Choi, J.: Biomimetics: forecasting the future of science, engineering, and medicine. Int. J. Nanomed. 10, 5701–5713 (2015)
Ganigara, A., Ravishankar, C., Ramavakoda, C., Nishtala, M.: Fatal hyperkalemia following succinylcholine administration in a child on oral propranolol. Drug. Metab. Pers. Ther. 30, 69–71 (2015)
Joshi, M.K., Pant, H.R., Tiwari, A.P., Maharjan, B., Liao, N., Kim, H.J., Park, C.H., Kim, C.S.: Three-dimensional cellulose sponge: fabrication, characterization, biomimetic mineralization, and in vitro cell infiltration. Carbohydr. Polym. 136, 154–162 (2016)
Yorulmaz, S., Jackman, J.A., Hunziker, W., Cho, N.J.: Supported lipid bilayer platform to test inhibitors of the membrane attack complex: insights into biomacromolecular assembly and regulation. Biomacromol. 16, 3594–3602 (2015)
Azevedo, H.S., Pashkuleva, I.: Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration. Adv. Drug Deliv. Rev. 94, 63–76 (2015)
Fisher, L.E., Yang, Y., Yuen, M.F., Zhang, W., Nobbs, A.H., Su, B.: Bactericidal activity of biomimetic diamond nanocone surfaces. Biointerphases 11(1), 011014. https://doi.org/10.1116/1.4944062. PMID: 26992656.011014 (2016)
Archana, D., Dutta, J., Dutta, P.K.: Evaluation of chitosan nano dressing for wound healing: characterization, in vitro and in vivo studies. Int. J. Biol. Macromol. 57, 193–203 (2013)
Kim, J.I., Pant, H.R., Sim, H.J., Lee, K.M., Kim, C.S.: Electrospun propolis/polyurethane composite nanofibers for biomedical applications. Mater. Sci. Eng. C Mater. Biol. Appl. 44, 52–57 (2014)
Mandal, A., Sekar, S., Seeni Meera, K.M., Mukherjee, A., Sastry, T.P., Mandal, A.B.: Fabrication of collagen scaffolds impregnated with sago starch capped silver nanoparticles suitable for biomedical applications and their physicochemical studies. Phys. Chem. Chem. Phys. 16, 20175–20183 (2014)
Penchala, S.C., Miller, M.R., Pal, A., Dong, J., Madadi, N.R., Xie, J., Joo, H., Tsai, J., Batoon, P., Samoshin, V., Franz, A., Cox, T., Miles, J., Chan, W.K., Park, M.S., Alhamadsheh, M.M.: A biomimetic approach for enhancing the in vivo half-life of peptides. Nat. Chem. Biol. 11, 793–798 (2015)
Wang, X.Y., Huang, Z.X., Chen, Y.G., Lu, X., Zhu, P., Wen, K., Fu, N., Liu, B.Y.: A multiple antigenic peptide mimicking peptidoglycan induced T cell responses to protect mice from systemic infection with staphylococcus aureus. PLoS ONE 10, e0136888 (2015)
Guarnieri, F.: Designing a small molecule erythropoietin mimetic. Methods Mol. Biol. 1289, 185–210 (2015)
Farrugia, B.L., Lord, M.S., Melrose, J., Whitelock, J.M.: Can we produce heparin/heparan sulfate biomimetics using “mother-nature” as the gold standard? Mol. 20, 4254–4276 (2015)
Datta, N.R., Krishnan, S., Speiser, D.E., Neufeld, E., Kuster, N., Bodis, S., Hofmann, H.: Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich’s “magic (nano)bullet” for cancer theranostics? Cancer Treat. Rev. 50, 217–227 (2016)
Boissenot, T., Bordat, A., Fattal, E., Tsapis, N.: Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: from theoretical considerations to practical applications. J. Control. Release 241, 144–163 (2016)
Wang, Z., Cabrera, M., Yang, J., Yuan, L., Gupta, B., Liang, X., Kemirembe, K., Shrestha, S., Brashear, A., Li, X., Porcella, S.F., Miao, J., Yang, Z., Su, X.Z., Cui, L.: Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in plasmodium falciparum from China-Myanmar border. Sci. Rep. 6, 33891 (2016)
Woodrow, C.J., White, N.J.: The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread. FEMS Microbiol. Rev. (2016)
Avitia-Dominguez, C., Sierra-Campos, E., Betancourt-Conde, I., Aguirre-Raudry, M., Vazquez-Raygoza, A., Luevano-De la Cruz, A., Favela-Candia, A., Sarabia-Sanchez, M., Rios-Soto, L., Mendez-Hernandez, E., Cisneros-Martinez, J., Palacio-Gastelum, M. G., Valdez-Solana, M., Hernandez-Rivera, J., De Lira-Sanchez, J., Campos-Almazan, M., Tellez-Valencia, A.: Targeting plasmodium metabolism to improve antimalarial drug design. Curr. Protein Pept. Sci. 17, 260–274 (2016)
Lawal, B., Shittu, O.K., Kabiru, A.Y., Jigam, A.A., Umar, M.B., Berinyuy, E.B., Alozieuwa, B.U.: Potential antimalarials from African natural products: a review. J. Intercult. Ethnopharmacol. 4, 318–343 (2015)
Marques, J., Valle-Delgado, J. J., Urban, P., Baro, E., Prohens, R., Mayor, A., Cistero, P., Delves, M., Sinden, R. E., Grandfils, C., de Paz, J. L., Garcia-Salcedo, J. A. & Fernandez-Busquets, X.: Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery. Nanomed (2016)
Unzueta, U., Cespedes, M.V., Vazquez, E., Ferrer-Miralles, N., Mangues, R., Villaverde, A.: Towards protein-based viral mimetics for cancer therapies. Trends Biotechnol. 33, 253–258 (2015)
Huang, P., Gao, Y., Lin, J., Hu, H., Liao, H.S., Yan, X., Tang, Y., Jin, A., Song, J., Niu, G., Zhang, G., Horkay, F., Chen, X.: Tumor-specific formation of enzyme-instructed supramolecular self-assemblies as cancer theranostics. ACS Nano 9, 9517–9527 (2015)
Garcia-Hevia, L., Fernandez, F., Gravalos, C., Garcia, A., Villegas, J.C., Fanarraga, M.L.: Nanotube interactions with microtubules: implications for cancer medicine. Nanomed. (Lond) 9, 1581–1588 (2014)
Fu, J., Wang, D., Mei, D., Zhang, H., Wang, Z., He, B., Dai, W., Wang, X., Zhang, Q.: Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release 204, 11–19 (2015)
Talbott, R.L., Borzilleri, R.M., Chaudhry, C., Fargnoli, J., Shen, H., Fairchild, C., Barnhart, B., Ortega, M., McDonagh, T.E., Vuppugalla, R., Vite, G.D., Hunt, J.T., Gottardis, M., Naglich, J.G.: Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport. Exp. Cell Res. 338, 251–260 (2015)
Duez, J., Holleran, J.P., Ndour, P.A., Pionneau, C., Diakite, S., Roussel, C., Dussiot, M., Amireault, P., Avery, V.M., Buffet, P.A.: Mechanical clearance of red blood cells by the human spleen: potential therapeutic applications of a biomimetic RBC filtration method. Transfus. Clin. Biol. 22, 151–157 (2015)
Villasante, A., Vunjak-Novakovic, G.: Tissue-engineered models of human tumors for cancer research. Expert Opin. Drug Discov. 10, 257–268 (2015)
Fan, Z., Lu, J.G.: Zinc oxide nanostructures: synthesis and properties. J. Nanosci. Nanotechnol. 5, 1561–1573 (2005)
Ozgur, U.A.Y., Liu, C., Teke, A., Reshchikov, M., Dogan, S., Avrutin, V., Cho, S., Morkoc, H.: A comprehensive review of ZnO materials and devices. Appl. Phy. Rev. 98, 1–103 (2005)
Ahmed, F., Arshi, N., Jeong, Y.S., Anwar, M.S., Dwivedi, S., Alsharaeh, E., Koo, B.H.: Novel biomimatic synthesis of ZnO nanorods using egg white (albumen) and their antibacterial studies. J. Nanosci. Nanotechnol. 16, 5959–5965 (2016)
Cerqueira, M.T., Pirraco, R.P., Marques, A.P.: Stem cells in skin wound healing: are we there yet? Adv. Wound. Care (New Rochelle) 5, 164–175 (2016)
Tuch, B.E.: Stem cells—a clinical update. Aust. Fam. Phys. 35, 719–721 (2006)
Kiatpongsan, S., Tannirandorn, Y., Virutamasen, P.: Introduction to stem cell medicine. J. Med. Assoc. Thai. 89, 111–117 (2006)
Mason, C., Dunnill, P.: A brief definition of regenerative medicine. Regen. Med. 3, 1–5 (2008)
Daar, A.S.: The future of replacement and restorative therapies: from organ transplantation to regenerative medicine. Transplant. Proc. 45, 3450–3452 (2013)
Christ, G.J., Saul, J.M., Furth, M.E., Andersson, K.E.: The pharmacology of regenerative medicine. Pharmacol. Rev. 65, 1091–1133 (2013)
Agrawal, N., Dasaradhi, P.V., Mohmmed, A., Malhotra, P., Bhatnagar, R.K., Mukherjee, S.K.: RNA interference: biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67, 657–685 (2003)
Kurisaki, K., Kurisaki, A., Valcourt, U., Terentiev, A.A., Pardali, K., Ten Dijke, P., Heldin, C.H., Ericsson, J., Moustakas, A.: Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol. Cell. Biol. 23, 4494–4510 (2003)
Jiang, Z.Y., Zhou, Q.L., Coleman, K.A., Chouinard, M., Boese, Q., Czech, M.P.: Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100, 7569–7574 (2003)
Hsieh, A.C., Bo, R., Manola, J., Vazquez, F., Bare, O., Khvorova, A., Scaringe, S., Sellers, W.R.: A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 32, 893–901 (2004)
Zender, L., Hutker, S., Liedtke, C., Tillmann, H.L., Zender, S., Mundt, B., Waltemathe, M., Gosling, T., Flemming, P., Malek, N.P., Trautwein, C., Manns, M.P., Kuhnel, F., Kubicka, S.: Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. USA 100, 7797–7802 (2003)
Zhou, T., Aumais, J.P., Liu, X., Yu-Lee, L.Y., Erikson, R.L.: A role for Plk1 phosphorylation of NudC in cytokinesis. Dev. Cell 5, 127–138 (2003)
Li, Q., Brass, A.L., Ng, A., Hu, Z., Xavier, R.J., Liang, T.J., Elledge, S.J.: A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl. Acad. Sci. USA 106, 16410–16415 (2009)
Bric, A., Miething, C., Bialucha, C.U., Scuoppo, C., Zender, L., Krasnitz, A., Xuan, Z., Zuber, J., Wigler, M., Hicks, J., McCombie, R.W., Hemann, M.T., Hannon, G.J., Powers, S., Lowe, S.W.: Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell 16, 324–335 (2009)
Whitehurst, A.W., Bodemann, B.O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J.D., Michnoff, C., Hao, W., Roth, M.G., Xie, X.J., White, M.A.: Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nat. 446, 815–819 (2007)
Struwe, W.B., Warren, C.E.: High-throughput RNAi screening for N-glycosylation dependent loci in Caenorhabditis elegans. Methods Enzymol. 480, 477–493 (2010)
Dominska, M., Dykxhoorn, D.M.: Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 123, 1183–1189 (2010)
Kong, J., Yu, X., Hu, W., Hu, Q., Shui, S., Li, L., Han, X., Xie, H., Zhang, X., Wang, T.: A biomimetic enzyme modified electrode for H2O2 highly sensitive detection. Analyst 140, 7792–7798 (2015)
Ma, H., Yan, T., Zhang, Y., Gao, P., Pang, X., Du, B., Wei, Q.: A biomimetic mussel-inspired photoelectrochemical biosensing chip for the sensitive detection of CD146. Analyst 140, 5019–5022 (2015)
Mascini, M., Macagnano, A., Monti, D., Del Carlo, M., Paolesse, R., Chen, B., Warner, P., D’Amico, A., Di Natale, C., Compagnone, D.: Piezoelectric sensors for dioxins: a biomimetic approach. Biosens. Bioelectron. 20, 1203–1210 (2004)
Parry, M.A., Andralojc, P.J., Scales, J.C., Salvucci, M.E., Carmo-Silva, A.E., Alonso, H., Whitney, S.M.: Rubisco activity and regulation as targets for crop improvement. J. Exp. Bot. 64, 717–730 (2013)
Jain, K., Mehra, N.K., Jain, N.K.: Potentials and emerging trends in nanopharmacology. Curr. Opin. Pharmacol. 15, 97–106 (2014)
Acknowledgements
I give credit to Dharmacon, RNAi, Gene expression and Gene editing (http://dharmacon.gelifesciences.com/applications/rna-interference/sirna/) for material on the segment on siRNA. I acknowledge the support of Dr. Meir Israelowitz, Dr. Birgit Weyand, Prof Kerstin Reimers (of blessed memory), Prof Peter Vogt and colleagues at Hanover Medical School, Germany, for supporting my wife and me through the years and showing us developments in Biomimetics and plastic surgery. I acknowledge Dr Afieharo Michael (my wife) for her contributions to this chapter and to my career. I acknowledge my mentor Professor Catherine Falade for her support and encouragement through the years. Credit goes to many more people and sources that I wish to say all are duly recognized with gratitude. I thank God for Grace, for all the support, and encouragement given to me towards completing this work.
Author information
Authors and Affiliations
Contributions
The author declares no competing interests.
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Michael, O.S. (2021). Emerging Biomimetic Approaches in the Optimization of Drug Therapies. In: Israelowitz, M., Weyand, B., von Schroeder, H., Vogt, P., Reuter, M., Reimers, K. (eds) Biomimetics and Bionic Applications with Clinical Applications. Series in BioEngineering. Springer, Cham. https://doi.org/10.1007/978-3-319-53214-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-53214-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53212-7
Online ISBN: 978-3-319-53214-1
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)